Clinical Diabetes Research

The objective of our team is to improve the lives of people with diabetes. Our expertise includes:

Clinical studies (phase 1-4) in diabetes technologies (CGM, insulin pump, AID) in type 1 diabetes
Clinical studies (Phase 1-4) of diabetes technologies in type 2 diabetes
Prevention of type 1 diabetes
Prevention of progression from prediabetes to type 2 diabetes
Epidemiology of diabetes complications
Adjunctive therapies such as GLP-1RA in type 1 diabetes management
Cardiovascular outcomes in type 1 diabetes
Clinical trials of therapeutics for type 1 and type 2 diabetes management

Get Involved

If you have diabetes, the best way you can help is to participate in research!

For start-ups, industry and non profits:

For clinical trials, contact our team.
For protocol and clinical trial development, please contact Viral Shah, MD.
Get involved with diabetes education via our Annual Diabetes Technology Certification Course.

Open clinical studies

Meet the Team

65385-Shah, Viral

Viral Shah, MD

Professor of Medicine

Lead Investigator

Linda DiMeglio

Linda A. DiMeglio, MD, MPH

Edwin Letzter Professor of Pediatrics

Collaborating investigator

Carmella Evans-Molina

Carmella Evans-Molina, MD, PhD

Director, Indiana Diabetes Research Center

Collaborating investigator

42354-Tariq, Zunera

Zunera Tariq, MD, MPH

Assistant Professor of Clinical Medicine

Collaborating investigator

70943-Bhasin, Kanchan

Kanchan Bhasin, MD

Postdoctoral Fellow in Medicine

Sana Kalaji, MD

Postdoctoral Fellow in Pediatrics

67050-Montaser, Eslam

Eslam Montaser, PhD

Postdoctoral Fellow in Medicine

Adrian Lyons

Clinical Research Manager

Kathy Bohanan

Kathy Bohanan

Clinical Research Nurse

Melissa Lodato

Melissa Lodato

Clinical Research Coordinator

Maria Spall

Nurse Leader, Pediatrics

Brittany Thorne

Regulatory Coordinator

In the News

Meet the Expert: Improving Diabetes Care Through Precision Medicine

Experts to give update on GLP-1 RAs and SGLT2i as adjuncts to automated insulin delivery

ADJUST-T1D Suggests Semaglutide Efficaciously Treats Type 1 Diabetes, with Viral Shah, MD

Breakthrough T1D Presents Dr. Viral Shah with the 2023 Mary Tyler Moore and S. Robert Levine, MD, Excellence in Clinical Research Award

Semaglutide benefits extend to type 1 diabetes

CGM may be beneficial for people without diabetes, but more research needed

Integrating CGM with GLP-1 RA Therapy: Clinical Evidence, Treatment Planning, and Overcoming Barriers in Managing T2DM

Providers should assess HbA1c and CGM metrics in diabetes management